ANADYS PHARMACEUTICALS INC Contracts & Agreements
89 Contracts & Agreements
- Business Finance (3 contracts)
- Business Operations (8)
- Human Resources (9)
- Mergers & Acquisitions (1)
- Real Estate (2)
- Uncategorized (66)
- AGREEMENT AND PLAN OF MERGER among: ANADYS PHARMACEUTICALS, INC., a Delaware corporation; HOFFMANN-LA ROCHE INC., a New Jersey corporation; BRYCE ACQUISITIONCORPORATION, a... (Filed With SEC on October 19, 2011)
- TENDER AND SUPPORT AGREEMENT (Filed With SEC on October 19, 2011)
- Current assets (Filed With SEC on May 5, 2011)
- AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 4, 2011)
- AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 4, 2011)
- AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 4, 2011)
- FIRST AMENDMENT TO LEASE (5871 Oberlin Drive) (Filed With SEC on March 4, 2011)
- LEASE AGREEMENT (Filed With SEC on March 4, 2011)
- AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on January 24, 2011)
- AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on January 24, 2011)
- 5,813,954 Stock (Filed With SEC on May 26, 2010)
- Current assets (Filed With SEC on October 30, 2009)
- Current assets (Filed With SEC on October 30, 2009)
- Financial Statements (Filed With SEC on July 31, 2009)
- Financial Statements (Filed With SEC on July 31, 2009)
- Financial Statements (Filed With SEC on July 31, 2009)
- Financial Statements (Filed With SEC on July 31, 2009)
- 8,358,000 Shares (Filed With SEC on June 4, 2009)
- ANADYS PHARMACEUTICALS, INC. (Filed With SEC on June 4, 2009)
- Current assets (Filed With SEC on May 1, 2008)
- Pursue the development of novel, high quality product candidates in major disease areas. We select our product candidates based on demonstrated properties that suggest the... (Filed With SEC on March 5, 2008)
- Pursue the development of novel, high quality product candidates in major disease areas. We select our product candidates based on demonstrated properties that suggest the... (Filed With SEC on March 5, 2008)
- Pursue the development of novel, high quality product candidates in major disease areas. We select our product candidates based on demonstrated properties that suggest the... (Filed With SEC on March 5, 2008)
- Pursue the development of novel, high quality product candidates in major disease areas. We select our product candidates based on demonstrated properties that suggest the... (Filed With SEC on March 5, 2008)
- Pursue the development of novel, high quality product candidates in major disease areas. We select our product candidates based on demonstrated properties that suggest the... (Filed With SEC on March 5, 2008)
- Pursue the development of novel, high quality product candidates in major disease areas. We select our product candidates based on demonstrated properties that suggest the... (Filed With SEC on March 5, 2008)
- Pursue the development of novel, high quality product candidates in major disease areas. We select our product candidates based on demonstrated properties that suggest the... (Filed With SEC on March 5, 2008)
- Pursue the development of novel, high quality product candidates in major disease areas. We select our product candidates based on demonstrated properties that suggest the... (Filed With SEC on March 5, 2008)
- Current assets (Filed With SEC on November 2, 2007)
- SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS (Filed With SEC on August 29, 2007)
- SEVERANCE AGREEMENT (Filed With SEC on March 15, 2007)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 15, 2007)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 15, 2007)
- Anadys Pharmaceuticals, Inc. Inducement Stock Option Agreement (Nonstatutory Stock Option) (Filed With SEC on September 25, 2006)
- Current assets (Filed With SEC on May 10, 2006)
- January 26, 2005 VIA HAND DELIVERY (Filed With SEC on March 15, 2006)
- Current assets (Filed With SEC on August 12, 2005)
- Current assets (Filed With SEC on August 12, 2005)
- Current assets (Filed With SEC on August 12, 2005)
- 5,000,000 ANADYS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 5, 2005)
- Current assets (Filed With SEC on November 12, 2004)
- Current assets (Filed With SEC on November 12, 2004)
- Current assets (Filed With SEC on August 16, 2004)
- Prospectus Summary (Filed With SEC on March 24, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on March 18, 2004)
- Prospectus Summary (Filed With SEC on January 12, 2004)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)
- Prospectus Summary (Filed With SEC on November 14, 2003)